In addition, carriers of a risk haplotype of the metabotropic glutamate receptor 3 (GRM3) for schizophrenia had lower EAAT2 expression in the prefrontal cortex as well as impaired cognitive function in respect of verbal fluency and list learning [17]. The gene discussed is SLC1A2; the disease is schizophrenia.